Be a Smart Investor
Tuesday, January 23, 2018
Bioverativ Inc. (BIVV) Vaulted To A New High After Bought By Sanofi
Bioverativ Inc. (BIVV) announced Monday morning that it has agreed to be acquired by Sanofi for $105 per share in cash, approximately $11.6 billion.
from RTT - Before the Bell http://ift.tt/2G9cwaA
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment